Lead party: Roche (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Kapa Biosystems, Inc.
Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Corporate Transactions, Venture Capital · Strategy: Acquisition, Venture Equity · Instrument: Equity · Deal amount: US$445m
Lead investor/buyer: Roche · Investors/buyers: Roche
Legal advisers: not identified in the source record.
Source: announced 19 August 2015. Original announcement: prnewswire.com.


